Found: 76
Select item for more details and to access through your institution.
Immunogenicity of 2 therapeutic mosaic HIV-1 vaccine strategies in individuals with HIV-1 on antiretroviral therapy.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-00876-2
- By:
- Publication type:
- Article
Human CD4-binding site antibody elicited by polyvalent DNA prime-protein boost vaccine neutralizes cross-clade tier-2-HIV strains.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-48514-8
- By:
- Publication type:
- Article
Comparison of the immunogenicity and protective efficacy of ACAM2000, MVA, and vectored subunit vaccines for Mpox in rhesus macaques.
- Published in:
- Science Translational Medicine, 2024, v. 17, n. 740, p. 1, doi. 10.1126/scitranslmed.adl4317
- By:
- Publication type:
- Article
Antibody‐mediated SARS‐CoV‐2 entry in cultured cells.
- Published in:
- EMBO Reports, 2023, v. 24, n. 12, p. 1, doi. 10.15252/embr.202357724
- By:
- Publication type:
- Article
Inadequate structural constraint on Fab approach rather than paratope elicitation limits HIV-1 MPER vaccine utility.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-42097-6
- By:
- Publication type:
- Article
Circularized Nanodiscs for Multivalent Mosaic Display of SARS-CoV-2 Spike Protein Antigens.
- Published in:
- Vaccines, 2023, v. 11, n. 11, p. 1655, doi. 10.3390/vaccines11111655
- By:
- Publication type:
- Article
Delayed and Attenuated Antibody Responses to Coronavirus Disease 2019 Vaccination With Poor Cross-Variant Neutralization in Solid-Organ Transplant Recipients—A Prospective Longitudinal Study.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 8, p. 1, doi. 10.1093/ofid/ofad369
- By:
- Publication type:
- Article
Autologous neutralizing antibodies increase with early antiretroviral therapy and shape HIV rebound after treatment interruption.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 695, p. 1, doi. 10.1126/scitranslmed.abq4490
- By:
- Publication type:
- Article
Rational Design and In Vivo Characterization of mRNA-Encoded Broadly Neutralizing Antibody Combinations against HIV-1.
- Published in:
- Antibodies (2073-4468), 2022, v. 11, n. 4, p. 67, doi. 10.3390/antib11040067
- By:
- Publication type:
- Article
Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoprotein.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32208-0
- By:
- Publication type:
- Article
Passive transfer of Ad26.COV2.S-elicited IgG from humans attenuates SARS-CoV-2 disease in hamsters.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-021-00427-z
- By:
- Publication type:
- Article
Antibody elicited by HIV-1 immunogen vaccination in macaques displaces Env fusion peptide and destroys a neutralizing epitope.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00387-4
- By:
- Publication type:
- Article
Broadly Neutralizing Antibodies for HIV-1 Prevention.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.712122
- By:
- Publication type:
- Article
Structural and genetic convergence of HIV-1 neutralizing antibodies in vaccinated non-human primates.
- Published in:
- PLoS Pathogens, 2021, v. 17, n. 6, p. 1, doi. 10.1371/journal.ppat.1009624
- By:
- Publication type:
- Article
Distinct clonal evolution of B-cells in HIV controllers with neutralizing antibody breadth.
- Published in:
- eLife, 2021, p. 1, doi. 10.7554/eLife.62648
- By:
- Publication type:
- Article
Poststudy Point-of-Care Oral Fluid Testing in Human Immunodeficiency Virus-1 Vaccinees.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 1, p. 1, doi. 10.1093/ofid/ofaa606
- By:
- Publication type:
- Article
Vaccine targeting SIVmac251 protease cleavage sites protects macaques against vaginal infection.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A broadly neutralizing macaque monoclonal antibody against the HIV-1 V3-Glycan patch.
- Published in:
- eLife, 2020, p. 1, doi. 10.7554/eLife.61991
- By:
- Publication type:
- Article
Characterization of Co-Formulated High-Concentration Broadly Neutralizing Anti-HIV-1 Monoclonal Antibodies for Subcutaneous Administration.
- Published in:
- Antibodies (2073-4468), 2020, v. 9, n. 3, p. 36, doi. 10.3390/antib9030036
- By:
- Publication type:
- Article
Durable protection against repeated penile exposures to simian-human immunodeficiency virus by broadly neutralizing antibodies.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-16928-9
- By:
- Publication type:
- Article
Structural basis of transmembrane coupling of the HIV-1 envelope glycoprotein.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-16165-0
- By:
- Publication type:
- Article
Hinge length contributes to the phagocytic activity of HIV-specific IgG1 and IgG3 antibodies.
- Published in:
- PLoS Pathogens, 2020, v. 16, n. 2, p. 1, doi. 10.1371/journal.ppat.1008083
- By:
- Publication type:
- Article
A microbial expression system for high-level production of scFv HIV-neutralizing antibody fragments in Escherichia coli.
- Published in:
- Applied Microbiology & Biotechnology, 2019, v. 103, n. 21/22, p. 8875, doi. 10.1007/s00253-019-10145-1
- By:
- Publication type:
- Article
Difficult-to-neutralize global HIV-1 isolates are neutralized by antibodies targeting open envelope conformations.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-10899-2
- By:
- Publication type:
- Article
First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector.
- Published in:
- 2018
- By:
- Publication type:
- journal article
TLR7 agonists induce transient viremia and reduce the viral reservoir in SIV-infected rhesus macaques on antiretroviral therapy.
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 439, p. 1, doi. 10.1126/scitranslmed.aao4521
- By:
- Publication type:
- Article
Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections.
- Published in:
- PLoS Pathogens, 2018, v. 14, n. 3, p. 1, doi. 10.1371/journal.ppat.1006860
- By:
- Publication type:
- Article
Correction: Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization.
- Published in:
- 2017
- By:
- Publication type:
- Correction Notice
Protection against a mixed SHIV challenge by a broadly neutralizing antibody cocktail.
- Published in:
- Science Translational Medicine, 2017, v. 9, n. 408, p. 1, doi. 10.1126/scitranslmed.aao4235
- By:
- Publication type:
- Article
Adenovirus prime, Env protein boost vaccine protects against neutralization-resistant SIVsmE660 variants in rhesus monkeys.
- Published in:
- Nature Communications, 2017, v. 8, n. 6, p. 15740, doi. 10.1038/ncomms15740
- By:
- Publication type:
- Article
Asymmetric recognition of HIV-1 Envelope trimer by V1V2 loop-targeting antibodies.
- Published in:
- eLife, 2017, p. 1, doi. 10.7554/eLife.27389
- By:
- Publication type:
- Article
Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller.
- Published in:
- Science Translational Medicine, 2017, v. 9, n. 373, p. 1, doi. 10.1126/scitranslmed.aal2144
- By:
- Publication type:
- Article
Potent and broad HIV-neutralizing antibodies in memory B cells and plasma.
- Published in:
- Science Immunology, 2017, v. 2, n. 7, p. 1, doi. 10.1126/sciimmunol.aal2200
- By:
- Publication type:
- Article
Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization.
- Published in:
- PLoS Pathogens, 2016, v. 12, n. 7, p. 1, doi. 10.1371/journal.ppat.1005742
- By:
- Publication type:
- Article
Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Production of Mucosally Transmissible SHIV Challenge Stocks from HIV-1 Circulating Recombinant Form 01_AE env Sequences.
- Published in:
- PLoS Pathogens, 2016, v. 12, n. 2, p. 1, doi. 10.1371/journal.ppat.1005431
- By:
- Publication type:
- Article
Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice.
- Published in:
- Nature Communications, 2016, v. 7, n. 2, p. 10618, doi. 10.1038/ncomms10618
- By:
- Publication type:
- Article
λ Light Chain Bias Associated With Enhanced Binding and Function of Anti-HIV Env Glycoprotein Antibodies.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Increased frequencies of CD8<sup>+</sup>CD57<sup>+</sup> T cells are associated with antibody neutralization breadth against HIV in viraemic controllers.
- Published in:
- Journal of the International AIDS Society, 2016, v. 19, n. 1, p. 1, doi. 10.7448/IAS.19.1.21136
- By:
- Publication type:
- Article
A New Glycan-Dependent CD4-Binding Site Neutralizing Antibody Exerts Pressure on HIV-1 In Vivo.
- Published in:
- PLoS Pathogens, 2015, v. 11, n. 10, p. 1, doi. 10.1371/journal.ppat.1005238
- By:
- Publication type:
- Article
Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies.
- Published in:
- PLoS Pathogens, 2015, v. 11, n. 8, p. 1, doi. 10.1371/journal.ppat.1005110
- By:
- Publication type:
- Article
Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117.
- Published in:
- Nature, 2015, v. 522, n. 7557, p. 487, doi. 10.1038/nature14411
- By:
- Publication type:
- Article
Molecular Evolution of Broadly Neutralizing Llama Antibodies to the CD4-Binding Site of HIV-1.
- Published in:
- PLoS Pathogens, 2014, v. 10, n. 12, p. 1, doi. 10.1371/journal.ppat.1004552
- By:
- Publication type:
- Article
First-in-Human Evaluation of a Hexon Chimeric Adenovirus Vector Expressing HIV-1 Env (IPCAVD 002).
- Published in:
- Journal of Infectious Diseases, 2014, v. 210, n. 7, p. 1052, doi. 10.1093/infdis/jiu217
- By:
- Publication type:
- Article
Promiscuous Glycan Site Recognition by Antibodies to the High-Mannose Patch of gp120 Broadens Neutralization of HIV.
- Published in:
- Science Translational Medicine, 2014, v. 6, n. 236, p. 1, doi. 10.1126/scitranslmed.3008104
- By:
- Publication type:
- Article
Vaccine delivery with microneedle skin patches in nonhuman primates.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 12, p. 1082, doi. 10.1038/nbt.2759
- By:
- Publication type:
- Article
Computational Prediction of Broadly Neutralizing HIV-1 Antibody Epitopes from Neutralization Activity Data.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0080562
- By:
- Publication type:
- Article
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys.
- Published in:
- Nature, 2013, v. 503, n. 7475, p. 224, doi. 10.1038/nature12744
- By:
- Publication type:
- Article
Strategic addition of an N-linked glycan to a monoclonal antibody improves its HIV-1-neutralizing activity.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 11, p. 1047, doi. 10.1038/nbt.2677
- By:
- Publication type:
- Article
Safety and Immunogenicity of Modified Vaccinia Ankara in Hematopoietic Stem Cell Transplant Recipients: A Randomized, Controlled Trial.
- Published in:
- Journal of Infectious Diseases, 2013, v. 207, n. 12, p. 1888, doi. 10.1093/infdis/jit105
- By:
- Publication type:
- Article